On the recordMay 16, 2022
I think that decision is going to have some pretty long-term consequences, particularly the CMS decision.
Source
congress.govRoy Blunt: “I think that decision is going to have some pretty long-term consequences, particularly the CMS decision.”
Editor's note · Context
Blunt expresses concern about the long-term impact of FDA and CMS decisions on drug approvals.
Share
More from Roy Blunt
Dec 6, 2023
Please continue this commitment and provide timely investments public health and research programs at the CDC and in the NIH.
Dec 18, 2022
I have been Chairman twice--let's see, I was Chairman, then Senator Shelby was Chairman, then I was Chairman again.
Dec 6, 2023
MCPP is thankful for the strong bipartisan support that the subcommittee leaders, Chairwoman Patty Murray and Ranking Member Roy Blunt, have shown in providing the NIH with its seventh consecutive funding increase during this time of…
Other voices in this conversation
